C., Potvin, D., Moyle, G., Soulban, G., Loughrey, H., Marsolais, C., Turner, R., & Grinspoon, S
Response: As we noted in the CY 2026 OPPS/ASC proposed rule (90 FR 33774), while REHs may have some familiarity and experience with reporting eCQMs when formerly operating as a subsection (d) hospital or a CAH participating in the Medicare Promoting Interoperability Program, we recognize that technological, monetary, and staffing barriers may present challenges to eCQM adoption and use in some REHs
Cellular Biochemistry 122, 19581967
Compounded GLP-1 medications offered through Body Good Studio are prepared by state-licensed, FDA-registered compounding pharmacies under Section 503A of the Federal Food, Drug, and Cosmetic Act, and are dispensed only pursuant to a valid prescription issued by a licensed medical provider